• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Microbiome modulators in the treatment of infectious diseases: insights from clinical trials.

作者信息

Wang Shidong, Wang Chenjuan, Shen Linhua, Zhu Mengjin, Wu Jiannong

机构信息

Department of Respiratory Medicine, Shaoxing Second Hospital, Shaoxing, Zhejiang, China.

Intensive Care Unit, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang, China.

出版信息

J Transl Med. 2024 Nov 18;22(1):1038. doi: 10.1186/s12967-024-05884-3.

DOI:10.1186/s12967-024-05884-3
PMID:39558400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11575062/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca41/11575062/0a021c93f43e/12967_2024_5884_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca41/11575062/0a021c93f43e/12967_2024_5884_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca41/11575062/0a021c93f43e/12967_2024_5884_Fig1_HTML.jpg

相似文献

1
Microbiome modulators in the treatment of infectious diseases: insights from clinical trials.微生物组调节剂在传染病治疗中的应用：来自临床试验的见解
J Transl Med. 2024 Nov 18;22(1):1038. doi: 10.1186/s12967-024-05884-3.
2
The clinical relevance of the microbiome when managing paediatric infectious diseases-Narrative review.微生物群在儿童传染病管理中的临床相关性——叙述性综述。
Acta Paediatr. 2021 Feb;110(2):441-449. doi: 10.1111/apa.15578. Epub 2020 Nov 10.
3
Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases.治疗胃肠道感染性疾病的肠道微生物组学靶向方法。
Int J Mol Sci. 2023 Oct 27;24(21):15654. doi: 10.3390/ijms242115654.
4
The Intestinal Microbiome in Infectious Diseases: The Clinical Relevance of a Rapidly Emerging Field.传染病中的肠道微生物群：一个迅速兴起领域的临床相关性
Open Forum Infect Dis. 2017 Jul 8;4(3):ofx144. doi: 10.1093/ofid/ofx144. eCollection 2017 Summer.
5
B-Group Vitamins as Potential Prebiotic Candidates: Their Effects on the Human Gut Microbiome.B 族维生素作为潜在的益生元候选物：它们对人类肠道微生物组的影响。
J Nutr. 2024 Feb;154(2):341-353. doi: 10.1016/j.tjnut.2023.12.038. Epub 2024 Jan 3.
6
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases.微生物组动态：抗击传染病的范式转变。
J Pers Med. 2024 Feb 18;14(2):217. doi: 10.3390/jpm14020217.
7
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment-insights from Phase II and III trials.消化疾病中的免疫：来自 II 期和 III 期临床试验的炎症性肠病治疗新药见解。
J Gastroenterol. 2024 Sep;59(9):761-787. doi: 10.1007/s00535-024-02130-x. Epub 2024 Jul 9.
8
The effect of gastrointestinal microbiome supplementation on immune checkpoint inhibitor immunotherapy: a systematic review.胃肠道微生物组补充剂对免疫检查点抑制剂免疫疗法的影响：系统评价。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7355-7362. doi: 10.1007/s00432-023-04656-8. Epub 2023 Mar 16.
9
Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.肠道微生物组特征可预测急性髓系白血病诱导治疗后的感染风险。
Clin Infect Dis. 2020 Jun 24;71(1):63-71. doi: 10.1093/cid/ciz777.
10
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota.一种用于评估干预方案对人体粪便微生物群影响的体外分批培养模型。
J Vis Exp. 2019 Jul 31(149). doi: 10.3791/59524.

引用本文的文献

1
Perspectives on Microbiome Therapeutics in Infectious Diseases: A Comprehensive Approach Beyond Immunology and Microbiology.传染病中微生物组疗法的展望：超越免疫学和微生物学的综合方法。
Cells. 2024 Dec 4;13(23):2003. doi: 10.3390/cells13232003.

本文引用的文献

1
Targeting the microbiome to improve human health with the approach of personalized medicine: Latest aspects and current updates.以个性化医疗为手段，靶向人体微生物组以改善人类健康：最新进展和现状更新。
Clin Nutr ESPEN. 2024 Oct;63:813-820. doi: 10.1016/j.clnesp.2024.08.005. Epub 2024 Aug 22.
2
Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases.益生菌作为补充剂在预防和治疗传染病中的现状。
Front Cell Infect Microbiol. 2022 Mar 14;12:789063. doi: 10.3389/fcimb.2022.789063. eCollection 2022.
3
Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?
益生菌和益生元：COVID-19 营养管理的潜在预防和治疗靶点？
Nutr Res Rev. 2023 Dec;36(2):181-198. doi: 10.1017/S0954422421000317. Epub 2021 Oct 20.
4
Update of treatment algorithms for Clostridium difficile infection.艰难梭菌感染治疗方案的更新。
Clin Microbiol Infect. 2018 May;24(5):452-462. doi: 10.1016/j.cmi.2017.12.022. Epub 2018 Jan 6.
5
The microbiome and critical illness.微生物组与危重病。
Lancet Respir Med. 2016 Jan;4(1):59-72. doi: 10.1016/S2213-2600(15)00427-0. Epub 2015 Dec 12.